- Home
- NEUE vs VNRX Comparison
NEUE vs VNRX Comparison
Compare NEUE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUE
- VNRX
- Stock Information
- Founded
- NEUE 2015
- VNRX N/A
- Country
- NEUE United States
- VNRX United States
- Employees
- NEUE N/A
- VNRX N/A
- Industry
- NEUE
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NEUE
- VNRX Health Care
- Exchange
- NEUE NYSE
- VNRX Nasdaq
- Market Cap
- NEUE 61.3M
- VNRX 52.4M
- IPO Year
- NEUE 2021
- VNRX N/A
- Fundamental
- Price
- NEUE $6.81
- VNRX $0.80
- Analyst Decision
- NEUE Hold
- VNRX Strong Buy
- Analyst Count
- NEUE 1
- VNRX 5
- Target Price
- NEUE $7.00
- VNRX $3.88
- AVG Volume (30 Days)
- NEUE 5.3K
- VNRX 308.2K
- Earning Date
- NEUE 08-06-2025
- VNRX 08-13-2025
- Dividend Yield
- NEUE N/A
- VNRX N/A
- EPS Growth
- NEUE N/A
- VNRX N/A
- EPS
- NEUE N/A
- VNRX N/A
- Revenue
- NEUE $907,349,000.00
- VNRX $1,308,361.00
- Revenue This Year
- NEUE $33.99
- VNRX $563.72
- Revenue Next Year
- NEUE $5.90
- VNRX $160.43
- P/E Ratio
- NEUE N/A
- VNRX N/A
- Revenue Growth
- NEUE N/A
- VNRX 64.16
- 52 Week Low
- NEUE $3.79
- VNRX $0.40
- 52 Week High
- NEUE $7.66
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- NEUE 50.30
- VNRX 75.61
- Support Level
- NEUE $6.77
- VNRX $0.40
- Resistance Level
- NEUE $6.83
- VNRX $0.75
- Average True Range (ATR)
- NEUE 0.05
- VNRX 0.08
- MACD
- NEUE -0.00
- VNRX 0.02
- Stochastic Oscillator
- NEUE 37.50
- VNRX 69.33
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.